Center for Medical Cannabis and Psilocybin

What is the Center for Medical Cannabis & Psilocybin?

The center includes the Medical Cannabis Program (MCP) and the Medical Psilocybin Program (MPP).

The Medical Cannabis Program (MCP) allows the beneficial use of medical cannabis in a regulated system to alleviate symptoms caused by debilitating medical conditions and their medical treatments.

The Medical Psilocybin Program (MPP) allows for the medical use of psilocybin, a naturally occurring psychedelic compound, to treat qualified medical conditions such as major treatment-resistant depression, PTSD, substance use disorders, and end-of-life care. The program is set to be fully implemented by December 31, 2027.

Publications

Featured

• Medical Cannabis Licensed Non-Profit Producer Re-Licensures List for 2018/2019 (General)
• Medical Cannabis Licensed Non-Profit Producer Re-Licensures List for 2017/2018 (General)
• Medical Cannabis Licensed Non-Profit Producer Re-Licensures List for 2016/2017 (General)

Latest

• Presentation - DACPC (3/30/26) (Meeting)
• Meeting Minutes - DACPC (3/30/26) (Meeting)
• Psilocybin Prep, Admin Integration (Meeting)

Popular

• Online Patient Portal – Patient Enrollment Instructions (Guide)
• Medical Cannabis Law Enforcement Fact Sheet (Policies, Protocols & Procedures)
• 1-2-3 Patient Instructions (Guide)
  • Instrucciones para el paciente 1-2-3

Resources

Latest

• Medical Psilocybin Advisory Board Meeting - March 20, 2026
• Dosage, Administration & Clinical Practice Committee - March 30, 2026
• Equity, Access, and Cultural Considerations Committee - March 24, 2026

Popular

• Medical Cannabis Advisory Board Hearing on MCP Rule Amendments – November 12, 2021
• Medical Cannabis Public Health & Safety Advisory Committee Meeting – December 15, 2021
• Medical Cannabis Advisory Board Meeting – December 12, 2021